Enzo Lalli
Enzo Lalli is an expert in Endocrinology at CNRS (France). Enzo Lalli has authored 129 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 479 (community average: 125). How the SLR is computed.
LeadR Profile
Endocrinology
Subspecialties: Oncology - Genetics
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1999 - 2026
Number : 129
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Baseline Tumor Transcriptional Features and Event-Free Survival After Anti-CD19 CAR T-Cell Therapy with Axicabtagene Ciloleucel in Large B-Cell Lymphoma: An Exploratory Reanalysis of the Randomized ZUMA-7 Trial. PMID 42930590 — cells, genes, disease-free survival, lymphoma, b-cell, lymphoma, neoplasms, biomarkers, therapeutics, t-lymphocytes, b-lymphocytes, tumor microenvironment, car-t cell | Med Sci (Basel) | 2026 | 0 |
| Distinct Transcriptional Programs Controlled by NR5A1 and β-Catenin in Adrenocortical Carcinoma. PMID 42646626 — cells, genes, catenins, chromatin, repression, psychology, adrenocortical carcinoma, regulon | Med Sci (Basel) | 2026 | 0 |
| DAX-1 in sex determination and gonadal development: revisiting the anti-testis hypothesis. PMID 42322018 — endocrinology, genes, gonads, sex, testis, gene expression | Endocr Rev | 2026 | 0 |
| The Steroidal Profile Modulates Adaptive Immune Response and Prognosis in Adrenocortical Carcinoma: Analysis of TCR and BCR Repertoires. PMID 42249652 — cells, neoplasms, phenotype, adrenocortical carcinoma, immunity, therapeutics, immunosuppression therapy, environment, steroids, tumor microenvironment, prognosis | Cancer Med | 2026 | 0 |
| Steroid Phenotype Stratification Reveals Distinct HLA Expression Signatures in Adrenocortical Carcinoma. PMID 41595150 — neoplasms, phenotype, antigen presentation, biomarkers, adrenocortical carcinoma, steroids, tumor microenvironment, prognosis | Cancers (Basel) | 2026 | 0 |
Clinical Studies 1
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 1
LeadR Networks
Main global connection map